MotherToBaby

Medications and More during pregnancy and breastfeeding

866.626.6847

COVID-19

Selected References:

  • Allotey J, et al. 2020. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ 370:m3320.
  • American College of Obstetricians and Gynecologists. 2020. Practice Advisory: Novel Coronavirus 2019 (COVID-19). Available at URL: https://www.acog.org/Clinical-Guidance-and-Publications/Practice-Advisories/Practice-Advisory-Novel-Coronavirus2019
  • American Society of Hematology. 2021. COVID-19 and VTE/anticoagulation: frequently asked questions. Available at URL: https://www.hematology.org/covid-19/covid-19-and-vte-anticoagulation
  • Angelidou A, et al. 2021. Association of maternal perinatal SARS-CoV-2 infection with neonatal outcomes during the COVID-19 pandemic in Massachusetts. JAMA Netw Open Apr 1;4(4):e217523.
  • Blumberg, DA, et al. 2020. Vertical transmission of SARS-CoV-2: what is the optimal definition? Am J Perinatol 37(8):769-772.
  • Centers for Disease Control and Prevention. 2020. Coronavirus (COVID-19). Available at URL: https://www.cdc.gov/coronavirus/2019-nCoV/index.html
  • Chambers, et al. 2020. Evaluation for SARS-CoV-2 in breast milk from 18 infected women. JAMA 324(13):1347-1348.
  • Chen H, et al. 2020. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet 395(10226):809-815.
  • Delahoy MJ, et al. 2020. Characteristics and maternal and birth outcomes of hospitalized pregnant women with laboratory-confirmed COVID-19 — COVID-NET, 13 states, March 1–August 22, 2020. MMWR Morb Mortal Wkly Rep 2020;69:1347–1354.
  • Ellington S, et al. 2020. Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status — United States, January 22–June 7, 2020. MMWR Morb Mortal Wkly Rep 2020;69:769–775.
  • Galang RR, et al. 2021. Risk factors for illness severity among pregnant women with confirmed SARS-CoV-2 infection – Surveillance for Emerging Threats to Mothers and Babies Network, 22 state, local, and territorial health departments, March 29, 2020 -March 5, 2021. Clin Infect Dis May 22:ciab432.
  • Gulersen M, et al. 2020. Clinical implications of SARS-CoV-2 infection in the viable preterm period. Am J Perinatol 37(11): 1077-1083.
  • Gurol-Urganci I, et al. 2021. Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study. Am J Obstet Gynecol May 20:S0002-9378(21)00565-2.
  • Holtmann N, et al. 2020. Assessment of SARS-CoV-2 in human semen – a cohort study. Fertility and Sterility 114 (2):233-238.
  • Jering K, et al. 2021. Clinical characteristics and outcomes of hospitalized women giving birth with and without COVID-19. JAMA Intern Med 181(5):714-717.
  • Khoury R, et al. 2020. MD Characteristics and outcomes of 241 births to women with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection at five New York City medical centers.  Obstetrics & Gynecology 136(2):273-282.
  • Li Y, et al. 2020. Lack of vertical transmission of severe acute respiratory syndrome coronavirus 2, China. Emerg Infect Dis 26(6):1335-1336.
  • Maeda MFY, et al. 2021. Vertical transmission of SARS-CoV2 during pregnancy: a high-risk cohort. Prenat Diag 8 July. Online ahead of print. DOI: https://doi.org/10.1002/pd.5980.
  • Norman M, et al. 2021. Association of maternal SARS-CoV-2 infection in pregnancy with neonatal outcomes. JAMA May 25;325(20):2076-2086.
  • Rosen H, et al. 2021. Fetal and perinatal outcome following first and second trimester COVID-19 infection: evidence from a prospective cohort study. J Clin Med May 16;10(10):2152.
  • Salvatore CM, et al. 2020. Neonatal management and outcomes during the COIVD-19 pandemic: an observation cohort study. Lancet Child & Adol Health 4(10):721-727.
  • Shah PS, et al. 2020. Classification system and case definition for SARS-CoV-2 infection in pregnant women, fetuses, and neonates. Acta Obstet Gynecol Scand 99: 565 68.
  • Shlomai NO, et al. 2021. Neonatal SARS-CoV-2 infections in breastfeeding mothers. Pediatrics May;147(5):e2020010918.
  • Villar J, et al. 2021. Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: the INTERCOVID multinational cohort study. JAMA Pediatr  Apr 22:e211050.
  • Vivanti AJ, et al. 2020. Transplacental transmission of SARS-CoV-2 infection. Nat Commun 11, 3572.
  • Wei SQ, et al. 2021. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. CMAJ Apr 19;193(16):E540-E548.
  • Wong YP, et al. 2021. The effects of COVID-19 on placenta and pregnancy: what do we know so far? Diagnostics (Basel) Jan 8;11(1):94.
  • Woodworth KR, et al. 2020. Birth and infant outcomes following laboratory-confirmed SARS-CoV-2 infection in pregnancy — SET-NET, 16 Jurisdictions, March 29–October 14, 2020. MMWR Morb Mortal Wkly Rep 69(44);1635–1640.
  • Zambrano LD, et al. 2020. Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status — United States, January 22–October 3, 2020. MMWR Morb Mortal Wkly Rep 69:769–75.
  • Zeng L, et al. Neonatal early-onset infection with SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan, China. JAMA Pediatr 174(7):722-725.
  • Zhu H, et al. 2020. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr 9(1):51-60.